- Orchiectomy, a surgical procedure involving the removal of one or both testicles, is increasingly recognized as a critical component of treatment for conditions such as testicular cancer, prostate cancer, and gender affirmation procedures. The market is expanding due to rising cancer incidence, improved surgical accessibility, and growing awareness around gender-affirming healthcare
- The growing demand for orchiectomy procedures is primarily driven by the increasing prevalence of testicular and prostate cancers, rising acceptance and demand for gender-affirming surgeries, and improved reimbursement frameworks in developed countries
- North America dominated the orchiectomy market with the largest revenue share of 41.6% in 2024, attributed to its advanced healthcare infrastructure, high awareness levels, and favorable insurance coverage for oncological and gender-affirming surgeries. The U.S. remains the key revenue contributor, supported by the growing number of specialty surgical centers and patient support programs
- Asia-Pacific is projected to be the fastest-growing region in the Orchiectomy market during the forecast period, registering a CAGR of 7.4% from 2025 to 2032. Factors such as rising cancer screening rates, growing access to surgical care, medical tourism, and increased awareness of gender dysphoria treatments in countries like India, Thailand, and South Korea are accelerating market expansion
- The Male to Female segment dominated the Orchiectomy market with a market share of 59.3% in 2024, driven by the increasing demand for gender-affirming procedures among transgender women and the expansion of supportive healthcare policies. This segment is further supported by growing awareness, improved access to specialized surgical centers, and broader insurance coverage, all contributing to its dominance in the market
